Nicholas Skipitaris, MD, director of electrophysiology at Lenox Hill Hospital is first in Manhattan to implant a new insertable cardiac monitor, the smallest cardiac monitoring device currently available.
Dr. Skipitaris implanted the innovative cardiac monitor in a 34-year old Manhattan woman. The device is approximately the size of a thick matchstick, making it more than 80 percent smaller than other ICMs. The device is used for patients who experience symptoms such as dizziness, palpitations, fainting and chest pain that may suggest a cardiac arrhythmia, as well as for those at an increased risk for cardiac arrhythmias.
As reported on the Lenox Hill Hospital website: “The LINQ ICM is a truly innovative monitoring device and a dramatic improvement over previous generations of this apparatus, which were cumbersome, required up to 30 minutes to implant, left a visible scar and did not transmit data,” said Dr. Skipitaris. “This device brings together the best of technology and science allowing us to treat our patients more efficiently and without interrupting their daily life.”
In addition to providing life-saving solutions to his patients and partaking in innovative surgeries, Dr. Skipitaris serves as one of Annuvia’s Medical Directors, overseeing AED programs across the country.